ConductScience.org, home

Trial · NCT07511400

The Role of NaV1.8 in Human Pain Models

NCT07511400, Early phase 1, Completed, Medical University of Vienna

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The Role of NaV1.8 in Human Pain Models. Trials, record NCT07511400. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07511400

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Role of NaV1.8 in Human Pain Models
NCT number
NCT07511400
Status
Completed
Phases
Early phase 1
Enrollment
67 participants, actual
Lead sponsor
Medical University of Vienna
Conditions
Pain, Acute Pain, Healthy Volunteer Study
Interventions
Suzetrigine, Lidocaine (drug), Control Solution
First posted
2026-04-06
Last updated
2026-06-24

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPain Intensity: Electrical stimulation1.5 minutes post-injection.
Metric: Numerical Rating Scale (0-100; 0=No pain, 100=Worst imaginable pain). Calculation: The average of all provided pain ratings divided by the number of delivered stimuli (maximum of 23 stimuli). If a subject stops the test upon reaching a rating of 30, the average is calculated based on the actual number of stimuli delivered.
PrimaryGeometric Mean Pain Intensity: Mechanical stimulation1.5 minutes post-injection.Metric: Numerical Rating Scale (0-100; 0=No pain, 100=Worst imaginable pain). Calculation: The geometric mean of the pain ratings recorded from three standardized mechanical stimuli (3.6N force).
PrimaryArea Under the Curve (AUC): Capsaicin injectionFrom injection until 0 pain for 30 seconds.
Metric: Numerical Rating Scale (0-100; 0=No pain, 100=Worst imaginable pain). Calculation: The AUC of pain ratings provided every 5 seconds, starting from the time of injection until a consecutive rating of 0 is maintained for 30 seconds.
PrimaryArea Under the Curve (AUC): Acid injection110 secondsMetric: Numerical Rating Scale (0-100; 0=No pain, 100=Worst imaginable pain). Calculation: The AUC of pain ratings provided every 5 seconds during the pH decrease from 7.2 to 5.4.
PrimaryArea Under the Curve (AUC): Heat injection150 secondsMetric: Numerical Rating Scale (0-100; 0=No pain, 100=Worst imaginable pain). Calculation: The AUC of pain ratings provided every 5 seconds during the temperature increase from 23°C to 52°C.
PrimaryArea Under the Curve (AUC): Cold injection150 secondsMetric: Numerical Rating Scale (0-100; 0=No pain, 100=Worst imaginable pain). Calculation: The AUC of pain ratings provided every 5 seconds during the temperature decrease from 23°C to 4°C.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07511400

GET https://conductscience.org/api/trials/v1/NCT07511400/registered